About us

AstraZeneca is one of the world's leading pharmaceutical companies, formed in 1999 following the merger of Astra AB and Zeneca group PLC. We provide innovative, effective prescription medicines in 6 important areas of medical need: anesthesia, cancer, cardiovascular, gastrointestinal, neuroscience and respiratory. Many of our products are world leaders.

Our corporate headquarters are in London UK and our R&D headquarters in Sodertalje, Sweden. Our products are available in over 100 countries and the healthcare sales in 2006 totalled $26.47 billion.

AstraZeneca has a strong research base. We spend over $14 million every working day on the research and development of new medicines that meet patient needs. (Total R&D spend in 2005: $3.4 billion). We employ 12,000 people in research and development at 14 R&D centres in 8 countries.

We have a promising early development pipeline, with 17 projects in phase ?, 15 projects in phase ? and 29 projects in phase ? development.

We have some 15,000 people at 27 manufacturing sites in 19 countries dedicated to ensuring we ca